In the in vitro assay, TanCAR-T cells showed cytotoxic activity against GBM cells bearing a single (EphA2+ or IL-13Rα2+) as well as dual (EphA2+ and IL-13Rα2+) target antigen. Here, EPHA2 is linked to glioblastoma.